These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31787321)

  • 1. C-reactive protein level predicts 30-day mortality and bleeding in patients with venous thromboembolism: A prospective single-center study.
    Demelo-Rodríguez P; Galeano-Valle F; Marcelo-Ayala A; Fernández-Carracedo E; Cuenca-Zarzuela A; Gómez-Morales M; Alvarez-Sala-Walther LA; Bellón-Cano JM; Del-Toro-Cervera J
    Med Clin (Barc); 2020 Jul; 155(2):51-56. PubMed ID: 31787321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence.
    Kunutsor SK; Seidu S; Blom AW; Khunti K; Laukkanen JA
    Eur J Epidemiol; 2017 Aug; 32(8):657-667. PubMed ID: 28718029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive Protein Can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding.
    Ichikawa T; Machida N; Kaneko H; Oi I; A Fujino M
    Intern Med; 2019 Feb; 58(4):487-495. PubMed ID: 30333404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis risk and survival in cancer patients with elevated C-reactive protein.
    Kanz R; Vukovich T; Vormittag R; Dunkler D; Ay C; Thaler J; Haselböck J; Scheithauer W; Zielinski C; Pabinger I
    J Thromb Haemost; 2011 Jan; 9(1):57-63. PubMed ID: 20874781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis.
    Jara-Palomares L; Solier-Lopez A; Elias-Hernandez T; Asensio-Cruz MI; Blasco-Esquivias I; Sanchez-Lopez V; de la Borbolla MR; Arellano-Orden E; Suarez-Valdivia L; Marin-Romero S; Marin-Barrera L; Ruiz-Garcia A; Montero-Romero E; Navarro-Herrero S; Lopez-Campos JL; Serrano-Gotarredona MP; Praena-Fernandez JM; Sanchez-Diaz JM; Otero-Candelera R
    Br J Cancer; 2018 Oct; 119(8):915-921. PubMed ID: 30318508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of cystatin C as a prognostic marker in venous thromboembolism].
    Calero-Paniagua I; Ruíz-Chicote AM; Nieto-Rodríguez JA; Ruiz-Ribó MD; Cortés Carmona AB
    Med Clin (Barc); 2014 Dec; 143(12):530-4. PubMed ID: 24216017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum C-reactive protein-to-albumin ratio may be a potential risk indicator for venous thromboembolism: Findings from a prospective cohort study.
    Kunutsor SK; Kurl S; Voutilainen A; Laukkanen JA
    Nutr Metab Cardiovasc Dis; 2023 Apr; 33(4):864-867. PubMed ID: 36740560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.
    Tafur AJ; Caprini JA; Cote L; Trujillo-Santos J; Del Toro J; Garcia-Bragado F; Tolosa C; Barillari G; Visona A; Monreal M;
    Thromb Haemost; 2017 Jun; 117(6):1192-1198. PubMed ID: 28276571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
    Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
    J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serum bilirubin levels in determining venous thromboembolism.
    Duman H; Özyurt S; Erdoğan T; Kara BY; Durakoğlugil ME
    J Vasc Surg Venous Lymphat Disord; 2019 Sep; 7(5):635-639. PubMed ID: 30922986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children.
    Carpenter SL; Goldman J; Sherman AK; Jeremiah Bell J; Selveraju S; Newland JG; Jarka DE; Chastain K; Selvarangan R
    Thromb Res; 2016 Feb; 138():69-73. PubMed ID: 26709039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.
    Sierros V; Fleming R; Cascioli M; Brady T
    Chron Respir Dis; 2009; 6(3):149-55. PubMed ID: 19643829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort.
    Folsom AR; Lutsey PL; Astor BC; Cushman M
    Thromb Haemost; 2009 Oct; 102(4):615-9. PubMed ID: 19806245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry.
    Bikdeli B; Jiménez D; Garcia-Tsao G; Barba R; Font C; Díaz-Pedroche MDC; Mazzolai L; Little DHW; Tufano A; Tafur AJ; Siegal D; Lip GYH; Monreal M;
    Semin Thromb Hemost; 2019 Nov; 45(8):793-801. PubMed ID: 31614388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein alone or combined with cardiac troponin T for risk stratification of respiratory intensive care unit patients.
    Ozsu S; Yilmaz G; Yilmaz I; Oztuna F; Bulbul Y; Ozlu T
    Respir Care; 2011 Jul; 56(7):1002-8. PubMed ID: 21352664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and risk of venous thromboembolism in the general population.
    Zacho J; Tybjaerg-Hansen A; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1672-8. PubMed ID: 20466978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein.
    Kunutsor SK; Seidu S; Katechia DT; Laukkanen JA
    Ann Med; 2018 May; 50(3):240-248. PubMed ID: 29448840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.